• First patient enrolled in pancreatic cancer study

    7 monthes ago - By Healio

    The Henry Ford Cancer Institute has announced that it has enrolled the first patient in a new trial to test the effectiveness of precise, higher dose MRI-guided radiation therapy to treat pancreatic cancer.
    “High-definition MRI and daily treatment plan adaptation allow us to deliver ablative radiation doses safely to pancreatic cancer patients for the first time ever,” Parag Parikh, MD, director of GI radiation oncology and MRI-guided radiation therapy at Henry Ford Cancer Institute, said in a press release.
    Parikh, who is co-principal investigator for the 5-year Stereotactic
    Read more ...